Skip to content

India to Resume Covid Vaccine Exports in 2022, Official Says

  • Expects six locally-developed shots approved by the year end
  • India isn’t banking on foreign imports to meet vaccine targets
A vial of the Covishield Covid-19 vaccine on a cold box during a 'door-to-door' vaccination drive at a village in the Budgam district of Jammu and Kashmir, India.

A vial of the Covishield Covid-19 vaccine on a cold box during a 'door-to-door' vaccination drive at a village in the Budgam district of Jammu and Kashmir, India.

Photographer: Sumit Dayal/Bloomberg
Updated on

India will likely restart exporting Covid-19 vaccines next year once it has immunized its own adult population, the head of an influential government expert panel said.

“Almost 60 countries are hardly having any access to vaccine and India should be able to provide a substantial portion in 2022,” N.K. Arora, chairman of the National Technical Advisory Group on Immunization in India, said in an interview with Bloomberg Television on Tuesday. “As soon as we are through with our adult population we should have sufficient vaccine to share with the rest of the world.”